Michael D Weil
Physician at Douglas Rd, Fort Collins, CO

License number
Colorado 34942
Issued Date
Nov 9, 1995
Renew Date
Jun 1, 2005
Expiration Date
May 31, 2007
Type
Physician
Address
Address
548 W Douglas Rd, Fort Collins, CO 80524

Professional information

Michael Weil Photo 1

Radiation Treatment System Utilizing Therapeutic Agent And Associated Identifier

US Patent:
2005013, Jun 16, 2005
Filed:
Oct 13, 2004
Appl. No.:
10/965434
Inventors:
Michael Weil - Fort Collins CO, US
Terrence Moore - Pleasant Hill CA, US
Michelle Svatos - Oakland CA, US
International Classification:
A61M003/00, A61N005/00, H05G001/00
US Classification:
600004000
Abstract:
A system may include a radiation treatment agent to treat tissue in response to received X-ray radiation and an identifier associated with the radiation treatment agent. The identifier may be usable to identify a radiation treatment plan. In some embodiments, a radiation treatment plan associated with a patient is generated, the radiation treatment plan is associated with an identifier and a patient identifier identifying the patient, a radiation treatment agent is prepared for delivery to the patient according to the radiation treatment plan, and the radiation treatment agent is associated with the identifier.


Michael Weil Photo 2

Determination Of Dose-Enhancing Agent Concentration And Dose Enhancement Ratio

US Patent:
2004011, Jun 17, 2004
Filed:
Dec 17, 2002
Appl. No.:
10/320906
Inventors:
William Collins - Clayton CA, US
Michael Weil - Fort Collins CO, US
International Classification:
A61B005/05
US Classification:
600/407000, 600/427000
Abstract:
A system includes a surface to support a body and a CT scanner to acquire, based on a first set of one or more CT scanning parameters, a first set of CT data representing a volume within the body including a dose-enhancing agent. The system further includes a processor to determine a CT number associated with the volume based on the first set of CT data, and to determine a dose enhancement corresponding to the dose-enhancing agent within the volume based on a stored association between the CT number, the first set of one or more scanning parameters, and the dose enhancement.


Michael Weil Photo 3

Dual-Use Radiation System

US Patent:
8243877, Aug 14, 2012
Filed:
Sep 12, 2007
Appl. No.:
11/853999
Inventors:
Michael D. Weil - Fort Collins CO, US
International Classification:
A61N 5/10
US Classification:
378 65, 600427
Abstract:
The present invention relates to the field of medical imaging and therapy of lesions that are detrimental to the body. The system is capable of both imaging and treatment with the same kilovoltage radiation source. Dual-use collimators produce a wide beam, which is not a pencil beam or a fan beam, to image and treat a target that has an enhanced radiation cross-section after taking up contrast agent containing a high-Z element. This results in increased radiation dose in the lesion. Furthermore, the significant drop in intensity of a low-energy radiation beam traveling through tissue is surmounted by continually aiming the beam at the target while moving it around the patient. Wide detectors opposing the radiation source permit the imaging and measurement of contrast in the target. More specifically this invention relates to a system, which optimizes delivery of kilovoltage x-rays to a lesion containing contrast agents in higher concentration than the surrounding normal tissues. Thereby subsequent delivery of radiation becomes cytotoxic upon interaction with the contrast.


Michael Weil Photo 4

Coupled Carriers For Enhancing Therapy

US Patent:
2007028, Dec 6, 2007
Filed:
Jun 5, 2007
Appl. No.:
11/758001
Inventors:
Michael Weil - Fort Collins CO, US
Assignee:
Sirius Medicine, LLC - Fort Collins CO
International Classification:
A61N 5/10, A61K 51/00, A61M 36/14
US Classification:
378065000, 424001110
Abstract:
Radiation has been used for many years to treat cancer patients. In the case of ionizing electromagnetic radiation, the incidental, extra dose to tissues surrounding the tumor is significant. The aim of this invention is to provide compounds and methods to enhance the absorbed radiation dose ratio, or other therapeutic compounds, in tumors verses normal tissue. The system concentrates contrast agents with high atomic number elements preferentially at the site of the tumor prior to administering radiotherapy, or preferentially concentrates other therapeutic compounds in the abnormal region. The agents are concentrated in a pathologic lesion following systemic or direct administration. Interaction of the ionizing radiation with the coupled compounds of this invention results in a significantly higher radiation dose to the tumor compared to surrounding tissues. The result is greater therapeutic efficacy with fewer side effects following treatment with low-energy radiation, or other agents. These compounds permit diagnostic uses in combination with the therapeutic use.


Michael Weil Photo 5

Management System For Combination Treatment

US Patent:
2006003, Feb 23, 2006
Filed:
Dec 7, 2004
Appl. No.:
11/007117
Inventors:
Michael Weil - Fort Collins CO, US
Terrence Moore - Pleasant Hill CA, US
Michelle Svatos - Oakland CA, US
International Classification:
A61N 5/10
US Classification:
378065000
Abstract:
Embodiments may include determination of a treatment plan associated with a patient, the treatment plan including a first treatment mode in which a treatment agent is present within a portion of the patient and a second treatment mode in which the portion of the patient is irradiated, determination, independent from the second treatment mode, of whether the first treatment mode meets a first safety threshold, determination, independent from the first treatment mode, of whether the second treatment mode meets a second safety threshold, and determination of whether a combination of the first treatment mode and the second treatment mode meets a third safety threshold.


Michael Weil Photo 6

Pharmaceutically Enhanced Low-Energy Radiosurgery

US Patent:
7481758, Jan 27, 2009
Filed:
Apr 1, 2002
Appl. No.:
10/113511
Inventors:
Michael Weil - Fort Collins CO, US
Kevin N. Morris - Denver CO, US
Assignee:
Sirius Medicine, LLC - Fort Collins CO
International Classification:
A61N 5/02
US Classification:
600 2, 378 51, 378 64, 378 65, 378119, 4241551, 424 852, 600431
Abstract:
Contrast agents developed specifically for x-ray diagnostics provide dose-enhanced radiotherapy and radiosurgery. The presence of heavy elements, for example, gold or iron, from these contrast agents, even small quantities, leads to a major dose increase in target tissue when combined with in vivo calibration of the amount of contrast agent. The technique can also be used in combination with other techniques, such as focused x-rays, to achieve further enhancement of therapeutic ratio. The technique is enhanced by employing oil-based contrast agents, which will remain in the target much longer than conventional agents. Through optimization of the equipment it is possible to achieve very large ratios of dose in target to dose in healthy tissue.


Michael Weil Photo 7

X-Ray Concentrator For Therapy

US Patent:
2003001, Jan 16, 2003
Filed:
Jun 20, 2002
Appl. No.:
10/176877
Inventors:
Webster Cash - Boulder CO, US
Michael Weil - Fort Collins CO, US
Kevin Morris - Denver CO, US
International Classification:
G21K001/06
US Classification:
378/084000
Abstract:
X-ray radiation from conventional electron-impact x-ray sources can be focused to very high intensity using a curved array of silicon wafers or other crystals having a spiral shape. This optic is of use for high-speed radiation treatment, radiosurgery, and radiotherapy.